The useful comparison is twelve-month total cost against what the fee actually buys, not the advertised monthly figure. Lavender Sky Health bills per consult with no membership, which puts it in a different structural category from subscription platforms such as Hims or Ro, from bundled clinical programs, and from manufacturer-direct self-pay channels. Normalize supply length first.
Four business models compete for the same patient
Direct-pay per visit is the model Lavender Sky Health uses. A flat fee covers the clinician’s time and the treatment plan, medication is billed separately or folded into a compounded plan price, and nothing recurs automatically. The entry cost is low and the ongoing cost depends almost entirely on what gets prescribed.
Monthly membership platforms take the opposite approach. Hims and Hers, Ro, and Found all charge a recurring fee that may or may not include the drug, and the number quoted in advertising frequently excludes it. The convenience is real. So is the risk of paying during months when nothing ships.
Bundled clinical programs sit at the top of the price range. Mochi Health, Henry Meds, and Ivim Health build more clinician contact and, in some cases, dietitian access into the monthly figure. Whether that represents value depends on whether the buyer actually uses the included services rather than paying for structure they ignore.
Manufacturer-direct self-pay is the fourth option and the one most often left out of provider roundups. LillyDirect for Zepbound and NovoCare for Wegovy sell the FDA-approved products at published self-pay prices. There is no compounding question, no pharmacy-choice puzzle, and no bundled coaching. Notably, the standard brand-name route at Lavender Sky Health points prescriptions at exactly these channels for a $25 monthly service fee, which makes the two approaches complementary rather than rival.
The lines between these four models blur in practice, which is why placing each provider in the column that matches how it truly bills matters more than the label it markets under. A provider such as HealthRX publishes its GLP-1 medications pricing openly, so a shopper can drop its numbers straight into the per-milligram math, whereas membership platforms like Found and Ro often quote a headline figure that hides the drug cost. The comparison only works once every option is expressed in the same units.
| Model | What the recurring fee covers | Drug included | Product status |
|---|---|---|---|
| Pay per consult | Nothing recurring; visits only | Only on compounded plans | Compounded or approved |
| Monthly membership | Access, messaging, sometimes the drug | Varies by tier | Usually compounded |
| Bundled program | Visits, coaching, medication | Usually yes | Usually compounded |
| Manufacturer direct | No platform fee | Purchased at list self-pay price | FDA-approved |
Normalize supply length before comparing anything
Two platforms quoting the same monthly price are often not selling the same thing. Lavender Sky Health ships its tier plans as two to two and a half month supplies and its extended plans as three to four month supplies, and it states plainly that total milligrams differ by pharmacy depending on available vial sizes and concentrations.
That makes any per-month figure an arithmetic product rather than a billing reality. The only honest comparison divides the full plan price by the milligrams delivered and by the number of days covered. A plan that looks fifteen percent cheaper can be twenty percent more expensive per milligram once the supply length is accounted for.
Formulation adds a second variable. Compounded preparations sometimes include added ingredients such as vitamin B12, glycine, or niacinamide. Approved products do not vary: what is in a Wegovy pen or a Mounjaro pen is fixed by the label, and that predictability is part of what the higher price buys.
Count the fees that are not the medication
Consult fees are the obvious one, and cadence matters more than the sticker. A platform charging $40 per follow-up every six months costs less annually than one charging $25 monthly for portal access. Restart fees after a lapse, lab charges, and shipping treated as an extra all belong in the same column.
Insurance handling is the line item people forget. Lavender Sky Health files no claims and completes no prior authorizations, which is a defensible position for a cash-pay practice but shifts real work onto the patient. Anyone whose plan might cover an approved anti-obesity medication should weigh that against a provider willing to pursue authorization, because coverage rules for prescription drug benefits determine whether the approved product is affordable at all.
Checking a provider’s own figures against a competitor’s write-up is a cheap sanity test, and the tirzepatide provider comparison published at formblends.com is one example of a rival seller documenting the same program. Pages like that are worth reading for the line items they surface and worth discounting for their conclusions.
Where each model tends to win
Lowest entry cost goes to pay-per-consult, particularly for someone transferring in on an established dose who needs a prescription written rather than a program joined. Lowest friction goes to membership platforms. The strongest evidentiary footing goes to manufacturer direct, since the published trial results were produced with the approved products at studied doses.
Bundled programs win for people who genuinely want the accountability and will attend the sessions. Comparative research suggests tirzepatide outperforms semaglutide on average weight reduction, but that finding is about molecules, not about vendors, and no telehealth company can claim it as a feature of its service.
The honest tradeoff underneath all of it is that cheaper compounded pricing generally means less clinician contact. That is not a scandal, it is the business model working as intended, and it suits plenty of people. It suits fewer people with complicated medical histories.
Six questions that separate the field faster than a price chart
Which pharmacy dispenses, and is it named before payment. How many total milligrams ship per plan, and across how many days. What triggers the next charge, a calendar date or a clinical event. What happens to money already paid if the plan is abandoned halfway. Which states the chosen pharmacy is licensed to ship into. And what the policy says when the pharmacy raises its price mid-plan, since medication pricing at compounding pharmacies is set by the pharmacy and can move without notice.
Frequently asked questions
Is a no-membership model always cheaper?
Not automatically. It removes charges during months with no order, which helps people who pause or space out refills. Someone ordering continuously at maximum cadence may find a bundled plan competitive once coaching, messaging, and included shipping are counted against the separate consult fees.
How do compounded prices compare with the approved drugs?
Compounded plans generally undercut manufacturer self-pay pricing, sometimes substantially. The gap reflects a real difference in product status: compounded preparations are not FDA-approved and are not reviewed by the agency for safety, effectiveness, or quality before sale.
Does choosing your own pharmacy actually matter?
It changes shipping speed, state availability, formulation additives, and vial concentrations, all of which affect cost per milligram. It also means the entity responsible for a damaged or delayed shipment is one the patient selected rather than one assigned by the platform.
Which alternative is best for someone with insurance coverage?
Usually a provider that will pursue prior authorization for an approved medication, or the manufacturer channel paired with a plan that covers it. Cash-pay compounded platforms are built around bypassing coverage, so the savings evaporate for anyone whose benefit would have paid for Wegovy or Zepbound.
Do provider reviews written by competitors have any value?
They can, for the specifics. Competitor pages tend to list pricing tiers, pharmacy disclosure practices, and consult formats accurately because those details are checkable. The rankings and verdicts attached to them are marketing, and should be read that way.
